Ross Levine, MD
Disclosures: Supervisory Board-Qiagen|Consulting Fee-Novartis AG|Ownership Interest-Loxo|Contracted Research-Celgene|Consulting Fee-Roche|Consulting Fee-Roche|Consulting Fee-Astellas|Ownership Interest-Isoplexis|Consulting Fee-Morphosys|Ownership Interest-C4
No Bio Available.